Norges Bank Amicus Therapeutics, Inc. Transaction History

Norges Bank

  • $736 Billion
  • Q4 2024

A detailed history of Norges Bank transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Norges Bank holds 3,082,036 shares of FOLD stock, worth $28.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,082,036
Holding current value
$28.3 Million
% of portfolio
0.0%

Shares

50 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$9.36 - $12.01 $28.8 Million - $37 Million
3,082,036 New
3,082,036 $29 Million
Q2 2024

Aug 14, 2024
BUY
$9.04 - $11.75 $26.4 Million - $34.4 Million
2,924,645 New
2,924,645 $29 Million
Q4 2023

Feb 09, 2024
BUY
$9.97 - $14.52 $25.2 Million - $36.8 Million
2,531,000 New
2,531,000 $35.9 Million
Q3 2023

Nov 13, 2024
BUY
$11.78 - $13.86 $28.5 Million - $33.5 Million
2,416,317 New
2,416,317 $29.4 Million
Q3 2023

Nov 13, 2023
SELL
$11.78 - $13.86 $51.3 Million - $60.4 Million
-4,356,740 Closed
0 $0
Q2 2023

Aug 14, 2024
BUY
$10.72 - $13.3 $3.88 Million - $4.81 Million
361,672 Added 12.37%
3,286,317 $41.3 Million
Q2 2023

Aug 14, 2023
SELL
$10.72 - $13.3 $30.5 Million - $37.8 Million
-2,844,902 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$10.91 - $13.54 $56.4 Million - $70 Million
5,169,419 New
5,169,419 $57.3 Million
Q4 2022

Feb 14, 2023
BUY
$9.89 - $12.7 $53.4 Million - $68.6 Million
5,400,086 New
5,400,086 $65.9 Million
Q3 2022

Nov 13, 2023
BUY
$9.82 - $12.75 $42.8 Million - $55.5 Million
4,356,740 New
4,356,740 $45.5 Million
Q2 2022

Aug 14, 2023
BUY
$6.23 - $11.12 $17.7 Million - $31.6 Million
2,844,902 New
2,844,902 $30.6 Million
Q1 2022

May 12, 2023
SELL
$7.89 - $12.48 $23.2 Million - $36.6 Million
-2,934,928 Reduced 54.35%
2,465,158 $23.3 Million
Q1 2022

May 09, 2022
SELL
$7.89 - $12.48 $22.4 Million - $35.4 Million
-2,836,238 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$9.82 - $12.44 $27.9 Million - $35.3 Million
2,836,238 New
2,836,238 $32.8 Million
Q3 2021

Nov 14, 2022
BUY
$8.74 - $11.84 $24.1 Million - $32.7 Million
2,762,681 New
2,762,681 $26.4 Million
Q3 2021

Nov 05, 2021
SELL
$8.74 - $11.84 $33.7 Million - $45.7 Million
-3,856,502 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$8.71 - $10.72 $33.6 Million - $41.3 Million
3,856,502 New
3,856,502 $37.2 Million
Q2 2021

Aug 10, 2021
SELL
$8.71 - $10.72 $19.1 Million - $23.5 Million
-2,188,692 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$9.2 - $23.86 $20.1 Million - $52.2 Million
2,188,692 New
2,188,692 $21.6 Million
Q1 2021

May 07, 2021
SELL
$9.2 - $23.86 $25.3 Million - $65.5 Million
-2,747,126 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$13.47 - $24.89 $37 Million - $68.4 Million
2,747,126 New
2,747,126 $63.4 Million
Q4 2020

Feb 10, 2021
SELL
$13.47 - $24.89 $50 Million - $92.4 Million
-3,710,730 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$12.89 - $15.89 $47.8 Million - $59 Million
3,710,730 New
3,710,730 $52.4 Million
Q3 2020

Nov 10, 2020
SELL
$12.89 - $15.89 $53.5 Million - $65.9 Million
-4,147,749 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$8.86 - $15.69 $36.7 Million - $65.1 Million
4,147,749 New
4,147,749 $62.5 Million
Q2 2020

Aug 07, 2020
SELL
$8.86 - $15.69 $31.9 Million - $56.4 Million
-3,597,470 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$6.63 - $11.16 $23.9 Million - $40.1 Million
3,597,470 New
3,597,470 $33.2 Million
Q1 2020

May 08, 2020
SELL
$6.63 - $11.16 $22.7 Million - $38.3 Million
-3,428,337 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$7.48 - $10.75 $25.6 Million - $36.9 Million
3,428,337 New
3,428,337 $33.4 Million
Q4 2019

Feb 12, 2020
SELL
$7.48 - $10.75 $18.7 Million - $26.9 Million
-2,503,099 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$8.02 - $13.25 $20.1 Million - $33.2 Million
2,503,099 New
2,503,099 $20.1 Million
Q3 2019

Nov 08, 2019
SELL
$8.02 - $13.25 $16.4 Million - $27.1 Million
-2,045,287 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$10.96 - $14.4 $22.4 Million - $29.5 Million
2,045,287 New
2,045,287 $25.5 Million
Q2 2019

Aug 09, 2019
SELL
$10.96 - $14.4 $17.1 Million - $22.5 Million
-1,561,885 Closed
0 $0
Q1 2019

May 11, 2020
BUY
$10.04 - $13.92 $855,187 - $1.19 Million
85,178 Added 5.77%
1,561,885 $21.2 Million
Q4 2018

Mar 04, 2019
BUY
$8.38 - $13.44 $12.4 Million - $19.8 Million
1,476,707 New
1,476,707 $14.1 Million
Q4 2018

Feb 08, 2019
SELL
$8.38 - $13.44 $12.4 Million - $19.8 Million
-1,476,707 Closed
0 $0
Q3 2018

Nov 12, 2019
BUY
$11.6 - $16.54 $17.1 Million - $24.4 Million
1,476,707 New
1,476,707 $17.9 Million
Q3 2018

Nov 09, 2018
SELL
$11.6 - $16.54 $17.1 Million - $24.4 Million
-1,476,707 Closed
0 $0
Q2 2018

Aug 12, 2019
BUY
$13.13 - $17.09 $19.4 Million - $25.2 Million
1,476,707 New
1,476,707 $23.1 Million
Q2 2018

Jul 23, 2018
SELL
$13.13 - $17.09 $19.4 Million - $25.2 Million
-1,476,707 Closed
0 $0
Q1 2018

May 15, 2019
BUY
$13.76 - $17.12 $20.3 Million - $25.3 Million
1,476,707 New
1,476,707 $22.2 Million
Q1 2018

May 09, 2018
SELL
$13.76 - $17.12 $17.2 Million - $21.4 Million
-1,247,933 Closed
0 $0
Q4 2017

Mar 05, 2018
BUY
$12.51 - $16.24 $15.6 Million - $20.3 Million
1,247,933 New
1,247,933 $18 Million
Q4 2017

Feb 09, 2018
SELL
$12.51 - $16.24 $15.6 Million - $20.3 Million
-1,247,933 Closed
0 $0
Q3 2017

Nov 13, 2018
BUY
$11.74 - $15.78 $14.7 Million - $19.7 Million
1,247,933 New
1,247,933 $18.8 Million
Q3 2017

Nov 07, 2017
SELL
$11.74 - $15.78 $7.34 Million - $9.87 Million
-625,365 Closed
0 $0
Q2 2017

Jul 24, 2018
SELL
N/A
-147,492 Reduced 19.08%
625,365 $6.3 Million
Q1 2017

May 11, 2018
SELL
N/A
-246,005 Reduced 24.15%
772,857 $5.51 Million
Q3 2016

Nov 13, 2017
BUY
N/A
1,018,862
1,018,862 $0

Others Institutions Holding FOLD

# of Institutions
312
Shares Held
311M
Call Options Held
467K
Put Options Held
515K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.58B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email